Search Trigger Search Trigger

Annual Report & Accounts for the year ended 30 June 2015

Delivering our global growth Strategy

Click here to view more on Delivering Our Strategy

An approach to Governance which enhances shareholder value

Click here to view more on Our Governance

Total Revenue

£203.5m

2014: £193.6m

CER*: Up 10.0%

£: Up 5.1%

Click here to view more

EU Pharma Revenue

£168.6m

2014: £172.4m

CER*: Up 3.9%

£: Down 2.2%

Click here to view more

NA Pharma Revenue

£34.9m

2014: £21.2m

CER*: Up 59.9%

£: Up 64.6%

Click here to view more

Underlying Operating Profit

£44.4m

2014: £42.2m

CER*: Up 11.6%

£: Up 5.2%

Click here to view more

Underlying Diluted Earnings per Share

39.90p

2014: 36.32p

CER*: Up 16.9%

£: Up 9.9%

Click here to view more

Dividend per Share

16.94p

2014: 15.40p

CER*: Up 10.0%

£: Up 10.0%

Click here to view more

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide.